PTGS2 and breast carcinoma: This study aims to investigate how the overexpression of miR-526b, miR-655, and COX-2 in breast cancer alters cellular responses to oxidative stress by assessing cell fate, DNA damage, and global transcriptional alteration via RNA-sequencing.